Evidence map›Paper›PMID 38100092›Full record

ArticleCPT: pharmacometrics & systems pharmacology2022

Deep compartment models: A deep learning approach for the reliable prediction of time-series data in pharmacokinetic modeling.

Alexander Janssen, Frank W G Leebeek, Marjon H Cnossen, Ron A A Mathôt, OPTI‐CLOT study group and SYMPHONY consortium

Open access · goldAbstract read
In one paragraph

Article in CPT: pharmacometrics & systems pharmacology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
4.5field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Low-dimensional neural ODEs and their application in pharmacokinetics.Journal of pharmacokinetics and pharmacodynamics · 2024
    Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Alexander JanssenDepartment of Clinical Pharmacology, Hospital Pharmacy, Amsterdam University Medical Center, Amsterdam, The Netherlands.ORCID 0000-0003-0719-0831
Frank W G LeebeekDepartment of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Marjon H CnossenDepartment of Pediatric Hematology, Erasmus University Medical Center-Sophia Children's Hospital, Rotterdam, The Netherlands.
Ron A A MathôtDepartment of Clinical Pharmacology, Hospital Pharmacy, Amsterdam University Medical Center, Amsterdam, The Netherlands.
OPTI‐CLOT study group and SYMPHONY consortium
Erasmus MC · NL

Funding

Dutch Organization for Scientific Research (NWO) NWA.1160.18.038
6 · The paper itself

Abstract

Nonlinear mixed effect (NLME) models are the gold standard for the analysis of patient response following drug exposure. However, these types of models are complex and time-consuming to develop. There is great interest in the adoption of machine-learning methods, but most implementations cannot be reliably extrapolated to treatment strategies outside of the training data. In order to solve this problem, we propose the deep compartment model (DCM), a combination of neural networks and ordinary differential equations. Using simulated datasets of different sizes, we show that our model remains accurate when training on small data sets. Furthermore, using a real-world data set of patients with hemophilia A receiving factor VIII concentrate while undergoing surgery, we show that our model more accurately predicts a priori drug concentrations compared to a previous NLME model. In addition, we show that our model correctly describes the changing drug concentration over time. By adopting pharmacokinetic principles, the DCM allows for simulation of different treatment strategies and enables therapeutic drug monitoring.

Indexed as

Deep LearningHemophilia AComputer SimulationHumansMachine LearningTime Factors

Identifiers

PMID38100092
PMCPMC9286722
OpenAlexW4281693881

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.